Phase 2 Extranodal NK T Cell Lymphoma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
Extranodal NK T Cell LymphomaHemophagocytic Lymphohistiocytosis (HLH)
Beijing Tongren Hospital25 enrolled1 locationNCT07525466
Recruiting
Phase 2
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Extranodal NK T Cell Lymphoma
Peking Union Medical College Hospital49 enrolled1 locationNCT06824883
Recruiting
Phase 2
Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL
Extranodal NK T Cell Lymphoma
Sun Yat-sen University90 enrolled1 locationNCT06406556
Recruiting
Phase 2
Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
NK-Cell LeukemiaExtranodal NK T Cell Lymphoma
The Affiliated Hospital of Xuzhou Medical University20 enrolled1 locationNCT05941156